RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Immune-Mediated Necrotising Myopathy: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Muscle Ultrasound in Immune-Mediated Necrotizing Myopathy: A Case Series
Anita Cunha et al. (18 October 2026)
https://doi.org/10.13140/rg.2.2.23348.82565
- 2.
Persistent HyperCKemia Beyond Post-Viral Myositis: A Case of Anti-HMGCR Immune-Mediated Necrotizing Myopathy
Xavier R et al. (16 October 2026)
https://europepmc.org/search?query=Persistent%20HyperCKemia%20Beyond%20Post-Viral%20Myositis%3A
- 3.
Exploring the landscape of flagellate erythema as a rare cutaneous symptom of idiopathic inflammatory myopathy: a case series-based review.
Opinc-Rosiak Aleksandra et al., Rheumatology international (14 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42873265/
- 4.
Statin-induced HMG-CoA reductase antibody-associated immune-mediated necrotising myopathy complicated by cardiac involvement.
White Laura M et al., BMJ case reports (13 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42869566/
- 5.
Patient-derived myobundles as a platform for modeling muscle weakness in rare pediatric rheumatic diseases: a proof-of-concept study
Avery Simon et al., BMC Rheumatology (8 October 2026)
https://doi.org/10.1186/s41927-026-00701-4
Clinical Trials : Currently Recruiting (Australia)
Ask your doctor whether you or your child may be eligible for any of these trials. Each has its ID and full eligibility criteria at the link shown.
- 1.
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
NCT06371417 · Recruiting · Phase 1 · Chugai Pharmaceutical
Ages 18 to 85
https://clinicaltrials.gov/study/NCT06371417
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Immune-Mediated Necrotising Myopathy
Immune-mediated necrotising myopathy is a rare autoimmune disease in which the immune system damages muscle fibres, causing weakness in the hips, thighs and shoulders that develops over weeks to months. It is often linked to anti-SRP or anti-HMGCR antibodies, the latter sometimes after statin use. Treatment combines steroids with other immune-suppressing medicines.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Common Questions
What is Immune-Mediated Necrotising Myopathy?
Immune-mediated necrotising myopathy is a rare autoimmune disease in which the immune system damages muscle fibres, causing weakness in the hips, thighs and shoulders that develops over weeks to months. It is often linked to anti-SRP or anti-HMGCR antibodies, the latter sometimes after statin use. Treatment combines steroids with other immune-suppressing medicines.
How many clinical trials are available for Immune-Mediated Necrotising Myopathy?
RareWays currently indexes 14 clinical trials for Immune-Mediated Necrotising Myopathy, of which 4 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Immune-Mediated Necrotising Myopathy come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Immune-Mediated Necrotising Myopathy.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.